Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
102.61
+0.38 (0.37%)
At close: Sep 18, 2026, 4:00 PM EDT
103.18
+0.57 (0.55%)
After-hours: Sep 18, 2026, 7:58 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 115,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 0.88% compared to the previous year.
Employees
115,000
Change (1Y)
1,000
Growth (1Y)
0.88%
Revenue / Employee
$405,087
Profits / Employee
$46,965
Market Cap
177.55B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
| Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
| Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
| Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
| Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
| Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
| Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
| Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
| Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
| Dec 31, 2012 | 91,000 | 0 | - |
| Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
| Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
| Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
| Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
| Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
| Dec 31, 2005 | 59,735 | -865 | -1.43% |
| Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
| Dec 31, 2003 | 72,200 | 381 | 0.53% |
| Dec 31, 2002 | 71,819 | 393 | 0.55% |
| Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
| Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
| Dec 31, 1999 | 57,100 | 864 | 1.54% |
| Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
| Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
| Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
| Dec 31, 1995 | 50,241 | 777 | 1.57% |
| Dec 31, 1994 | 49,464 | -195 | -0.39% |
| Dec 31, 1993 | 49,659 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Medtronic | 95,000 |
| Koninklijke Philips | 65,340 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
ABT News
- 2 days ago - Abbott declares 411th consecutive quarterly dividend - PRNewsWire
- 5 days ago - Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept says - Reuters
- 5 days ago - Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall - PRNewsWire
- 9 days ago - Here are the stocks to favor in the fourth quarter — and those you should avoid - Market Watch
- 11 days ago - Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms - PRNewsWire
- 19 days ago - Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula - PRNewsWire
- 23 days ago - Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke - PRNewsWire
- 25 days ago - FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients - Reuters